Title |
Pharmacological interventions for pain in children and adolescents with life‐limiting conditions
|
---|---|
Published in |
Cochrane database of systematic reviews, March 2015
|
DOI | 10.1002/14651858.cd010750.pub2 |
Pubmed ID | |
Authors |
Emma Beecham, Bridget Candy, Richard Howard, Renée McCulloch, Jo Laddie, Henrietta Rees, Victoria Vickerstaff, Myra Bluebond‐Langner, Louise Jones |
Abstract |
Pain is one of the most common symptoms in children and young people (CYP) with life-limiting conditions (LLCs) which include a wide range of diagnoses including cancer. The current literature indicates that pain is not well managed, however the evidence base to guide clinicians is limited. There is a clear need for evidence from a systematic review to inform prescribing. |
X Demographics
The data shown below were collected from the profiles of 93 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 17 | 18% |
Spain | 11 | 12% |
United States | 8 | 9% |
Canada | 3 | 3% |
Colombia | 3 | 3% |
France | 3 | 3% |
New Zealand | 2 | 2% |
Australia | 2 | 2% |
Netherlands | 2 | 2% |
Other | 15 | 16% |
Unknown | 27 | 29% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 63 | 68% |
Practitioners (doctors, other healthcare professionals) | 14 | 15% |
Scientists | 11 | 12% |
Science communicators (journalists, bloggers, editors) | 4 | 4% |
Unknown | 1 | 1% |
Mendeley readers
The data shown below were compiled from readership statistics for 480 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 2 | <1% |
Chile | 1 | <1% |
United States | 1 | <1% |
South Africa | 1 | <1% |
Unknown | 475 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 78 | 16% |
Researcher | 53 | 11% |
Student > Bachelor | 42 | 9% |
Student > Ph. D. Student | 38 | 8% |
Student > Doctoral Student | 26 | 5% |
Other | 92 | 19% |
Unknown | 151 | 31% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 152 | 32% |
Nursing and Health Professions | 59 | 12% |
Psychology | 26 | 5% |
Social Sciences | 14 | 3% |
Pharmacology, Toxicology and Pharmaceutical Science | 8 | 2% |
Other | 45 | 9% |
Unknown | 176 | 37% |
Attention Score in Context
This research output has an Altmetric Attention Score of 71. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 November 2023.
All research outputs
#607,233
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#1,094
of 11,499 outputs
Outputs of similar age
#7,364
of 276,853 outputs
Outputs of similar age from Cochrane database of systematic reviews
#29
of 256 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 276,853 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 256 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.